FARBRIDGE PHARMA CONSULTING

Serial Number 99258951
686

Registration Progress

Application Filed
Jun 30, 2025
Under Examination
Approved for Publication
Dec 23, 2025
Published for Opposition
Dec 23, 2025
Registered

Attorney Assistance

Published for Opposition
Due: Jan 22, 2026 25 days

Trademark Image

FARBRIDGE PHARMA CONSULTING

Basic Information

Serial Number
99258951
Filing Date
June 30, 2025
Published for Opposition
December 23, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
686
Status Date
Dec 23, 2025
Application
Pending
Classes
042

Rights Holder

Farbridge Pharma Consulting, LLC

16
Address
7465 Mission Gorge Road
Suite 123
San Diego, CA 92120

Ownership History

Farbridge Pharma Consulting, LLC

Original Applicant
16
San Diego, CA

Farbridge Pharma Consulting, LLC

Owner at Publication
16
San Diego, CA

Legal Representation

Attorney
Edward N. Benito

USPTO Deadlines

Next Deadline
25 days remaining
Published for Opposition
Due Date
January 22, 2026
Extension Available
Until February 22, 2026

Application History

13 events
Date Code Type Description Documents
Dec 23, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 23, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 17, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 24, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 24, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 24, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 24, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 24, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 18, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 7, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 7, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 30, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 30, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Consulting services in the field of biotechnology; Consulting services in the field of genetic science; Consulting services in the field of pharmaceutical research and development; Pharmaceutical drug development services
First Use Anywhere: Jul 17, 2023
First Use in Commerce: Jul 17, 2023

Additional Information

Design Mark
The mark consists of a stylized whirlpool symbol that transitions from light blue to dark blue in a clockwise direction. To the right of the design is the stylized gray wording "FARBRIDGE", below which is the stylized gray wording "PHARMA CONSULTING". The white in the drawing represents background and is not a feature of the mark.
Color Claim
The color(s) light blue, dark blue, and gray are claimed as a feature of the mark.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA CONSULTING"